Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.

BMC Clin Pharmacol · 2011 · PMC3119167 · PMID 21609444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Two meta-analyses have suggested that RGZ increases the risk of myocardial infarction but did not reach statistical significance for cardiovascular death [ 14 , 15 ], but the reviews published in 2010 led to the rosiglitazone withdrawal from the European market in September 2010.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.